INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/ INVESTOR MEET07-12-2021
07-12-2021
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors Meet23-11-2021
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors Meet22-11-2021
INDOCO REMEDIES LTD. - 532612 - Related Party Transactions Pursuant To Reg 23(9) Of SEBI (LODR) Reg, 2015 (Listing Regulations)
Related party transactions pursuant to Reg 23(9) of SEBI (LODR) Reg, 2015 (Listing Regulations)15-11-2021
Accumulate Indoco Remedies; target of Rs 480: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 480 in its research report dated November 04, 2021.05-11-2021
INDOCO REMEDIES LTD. - 532612 - Audio Recording Of Conference Call Held On November 02, 2021
Audio recording of Conference Call held on November 02, 202103-11-2021
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Un-Audited Financial Results for the quarter ended 30.09.202103-11-2021
Earnings Call for Q2FY22 of Indoco Remedies
Conference Call with Indoco Remedies Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.02-11-2021
Indoco Remedies Ltd - 532612 - Reappointment Of Managing Director And Jt. Managing Director For A Further Period Of 5 Years
Reappointment of Managing Director and Jt. Managing Director for a further period of 5 years02-11-2021
Indoco Remedies Ltd - 532612 - Appointment Of Mr. Pramod Ghorpade As CFO Of The Company
Appointment of Mr. Pramod Ghorpade as CFO of the Company02-11-2021